THE urinary excretion of cestrogens, pregnanediol and pituitary gonadotrophins was studied throughout nine ovulatory menstrual cycles. Particular attention was given to correlating the cyclical changes in the excretion of one hormone with those of the others. Basal temperature records were also kept and where possible any change in basal temperature was correlated with the pattern of hormone excretion.
Only assay methods of proved reliability were used in this study. It is therefore likely that the results reported herein are more meaningful from the quantitative point of view than any previously reported. The reliability criteria of the individual methods have been reviewed elsewhere (Coyle et al., 1956; Brown et al., 1957; Loraine, 1958) .
The most notable feature of the results obtained was the constancy of the hormonal excretion pattern from one individual to another although the actual quantities excreted varied considerably in different subjects. The values obtained for the excretion of cestrogens and pregnanediol were quantitatively very similar to those reported by Brown (1955b) and by Klopper (1957) in a previous series of cases.
In all 9 subjects in whom the urinary gonadotrophin excretion was estimated by the mouse uterus test the output during the follicular and luteal phases of the cycle was low, being generally less than 10 HMG units per twenty-four hours. In 7 of the 9 cases a definite peak in gonadotrophin excretion ranging from 13 to 40 HMG units per twenty-four hours was observed at approximately mid-cycle; in the remaining two subjects this rise was absent. In one patient with mammary carcinoma the gonadotrophin excretion was studied first during a menstrual cycle and secondly subsequent to ovarian irradiation. It was found that immediately after radiotherapy the excretion values rose steeply and approximately one month after treatment were some twenty times higher than those found in the follicular and luteal phases of the cycle. When gonadotrophin assays were conducted by the mouse uterus and hypophysectomized rat prostate tests it was noted that the results obtained agreed very closely and that the ratio of potencies of the two methods one to another was approximately unity at all stages of the cycle. A similar observation has recently been made by Buchholz (1957) . It is generally believed that the amounts of FSH and ICSH elaborated by the anterior pituitary fluctuate independently during the menstrual cycle. Since the two assay methods presumably measure different types of gonadotrophic activity, it might have been anticipated that the presence in urine of variable proportions of FSH and ICSH would be reflected in varying potency ratios. The finding throughout of a potency ratio in the neighbourhood of unity suggests either that the extract contains a single gonadotrophin with two activities or that it contains two gonadotrophins which are always present in the same relative proportions. The fact that ICSH activity as determined by the hypophysectomized rat prostate test, could usually be demonstrated in urine at all stages of the menstrual cycle conflicts with the generally accepted view that this hormone is secreted only at the time of ovulation and in the early luteal phase of the cycle. 2Present address: Obstetric Medicine Research Unit, Aberdeen University Medical School Foresterhill, Aberdeen.
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Peaks of excretion of cestrogens and of gonadotrophins were characteristic features at mid-cycle. The present study has demonstrated that the relationship in time of these two peaks is variable. In some individuals the two peaks occurred simultaneously; in others the gonadotrophin peak followed the cestrogen peak by periods ranging from one to four days. It is of considerable interest that in none of the subjects studied did the gonadotrophin peak precede the cestrogen peak. If the assumption is made that gonadotrophins are eliminated in urine as rapidly as cestrogens, it would appear reasonable to conclude that the peak of cestrogen excretion could not have been initiated by the increase in gonadotrophin output.
In 7 out of 8 subjects the luteal phase rise in pregnanediol occurred at approximately the sam'e time as the rise in basal temperature; in one patient there was no increase in basal temperature during the luteal phase but the pattern of hormone excretion was normal.
The luteal increase in urinary pregnanediol occurred after the cestrogen peak, the time interval ranging from one to four days.
In the majority of subjects the overall rise and fall of cestrogen levels paralleled those of pregnanediol. However there appeared to be no correlation between the actual amounts of cestrogen and pregnanediol excreted.
One patient in the present series was successfully inseminated and became pregnant during the period of study. The pregnancy proceeded uneventfully to term. The first indication that pregnancy had supervened was a sharp rise in gonadotrophin excretion occurring nine days after insemination; it is possible that this rise was due to the presence in urine of human chorionic gonadotrophin (HCG) rather than pituitary gonadotrophins. The increase in gonadotrophin excretion was followed by a rise in aestrogen excretion and a maintenance of the high luteal phase level of pregnanediol. In this patient the insemination was performed on the day of the cycle in which the peak of excretion of cestrone and cestradiol-17( was expected. It is of interest to note that previous inseminations performed at the time of the rise in basal temperature had been unsuccessful.
The substance of this paper will be published in full in the Journal of Endocrinology. THIS substance has been examined for its effect in balance studies, adrenal steroid suppression, gonadotrophin suppression and androgenicity. Doses of 100 mg. per day intramuscularly, or orally have been used and are now regarded as excessive, 50 mg. per day appears as effective and may also be too large. In all of 10 patients nitrogen retention occurred, the average in 6 over two weeks of treatment being 3 0 grams per day. There have been interesting effects on calcium balance, significant falls in fmcal calcium occurring, particularly during the first week. There has been a uniform fall of urine calcium, which appears to persist during treatment (average 49 mg. per day, range 14-154 mg.). In all instances phosphorus retention was proportional to nitrogen and calcium. Potassium retention has exceeded the requirement of nitrogen by about 8 mEq. per day. Sodium and water retention can occur, but not consistently. In view of the tendency for nitrogen and particularly frcal calcium to "escape" a long term study was made in a boy with fragilitas ossium. Control nitrogen retention (1 -4 grams per day) increased to 2X9 grams on 50 mg. ethyl nortestosterone and calcium balance became positive (135 mg. per day). After six months treatment nitrogen retention was only 1-0 gram but calcium 178 mg. Urine calcium also remained at half the control level of 115 mg. per day. During these six months weight gain was 6 5 kg. with clinical development of muscle, compared with no weight gain during the six months preceding treatment.
The only significant alteration in serum chemistry has been in the phosphorus level, which falls about 20% and appears to continue with treatment. In a breast cancer patient serum phosphorus rose from 3 4 to 6-6 mg.% after oophorectomy and during forty-two days of therapy remained below 3 0 mg. %.
The steroid should suppress the catabolic effects of cortisone and prednisone, and has been of value in this respect in 2 patients with skin disease who developed osteoporosis due to large doses of these substances. The pattern of response was similar to that in the first group of patients and the fall in fmcal calcium appeared not to persist.
A fall in both urine ketosteroids and ketogenic steroids was noted. In 5 patients ketosteroids fell significantly (4 male and an oophorectomized female for breast cancer). The ketogenic steroids fell in the males but, curiously, not in the woman. The ketosteroids were studied in detail by the method of Brooks (1958) , in 3 of the males and the woman. There was a significant fall in the steroids of adrenal origin: dehydroepiandrosterone (1 male excepted) and 1 1-hydroxyaetiocholanolone, the latter primarily arising from cortisol (Dorfman, 1954) . The corresponding 11-keto compound, present in small amounts also fell. The adrenal ketostero'id A4-androstenedione is normally metabolized to androsterone and etiocholanolone (which also arise from testosterone). The intramuscular administration of approximately 45 mg. of androstenedione to a male with peptic ulceration resulted in a recovery of approximately 45 % of the dose as these two metabolites and the amount was not altered by simultaneous administration of ethylnortestosterone. This shows that the reduction of the adrenal component of these two metabolites by ethylnortestosterone is not due to altered metabolism. That there is such a reduction of the adrenal component was well shown in the oophorectomized woman. There may, of course, be in the male also a suppression of testosterone secretion, but we have no direct evidence for this.
The effect of ethylnortestosterone on gonadotrophin excretion in 4 patients with elevated resting levels (Turner's syndrome, post-menopause and eunuchoidism) has been studied. Doses of 100 to 150 mg. per day produced little evidence of suppression, except possibly' in one patient during the second week of treatment.
There is no doubt that ethylnortestosterone has androgenic properties. This point has been studied in the breast cancer patient, 2 eunuchoids and a boy of 5 years with fragilitas ossium. It seems markedly less androgenic than testosterone, but continued use of 20 mg. daily for seven weeks produced penile enlargement and visible growth of pubic hair in the small boy. Further experience is required to appraise its real clinical usefulness as an anabolic agent. Analysis of assay data obtained using commercial preparations of ACTH and our own colony of rats, showed that provided at least 4 rats were injected with a single dose of plasma or serum, and that the mean depletion of ascorbic acid produced by the single dose of unknown was at least 60 mg. then 0-6 i.mu. ACTH could be detected 95 times out of 100. Hypophysectomized rats tolerate 2 ml. and frequently 4 ml. of plasma or serum injected intravenously per 100 grams body-weight.' The assay therefore detects 15 i.mu. ACTH/ 100 ml. plasma or serum. ACTH is therefore not detected in the blood of normal patients or unstressed animals.
Most assays have been semiquantitative only and performed according to the method of Brill et al. (1956) . That the results are of the right order of magnitude is supported by the following experiment. A preparation of pituitary ACTH (J 10602, Armour Laboratories Limited) was assayed against La-l-A and a patient with rheumatoid arthritis was then infused intravenously with it at the rate of 184 i.mu./minute. Prior to infusion her plasma contained no detectable ACTH. Towards the end of the infusion, her plasma was assayed and found to contain 36-1 i.mu. ACTH/100 ml. The theoretical concentration of ACTH would be 307 i.mu./100 ml. plasma, presuming that the half-life of ACTH is five minutes, and that it is confined to the vascular compartment (Sayers, 1955) .
The concentration of ACTH in the plasma of some patients is given in Table I . It is generally agreed that ACTH is readily detectable in untreated Addison's disease (Sydnor et al., 1953 ) and a raised level was found in Mrs. W. (Table I) (Prunty, 1956) with increased urinary steroids and marked sodium retention. No ACTH was detectable in her plasma. Though Mr. B. responded to a standard ACTH test, sodium retention was poor and his urinary excretion of 17-ketogenic steroids did not exceed 37 mg./day. His plasma ACTH was however high, and it is perhaps possible that he was in the process of developing classical Addison's disease, especially as his history only extended back two months.
Details concerning 4 patients with Cushing's syndrome are given in a footnote to Table I , Plasma ACTH was high in 3 of them. In 9 patients reported in the literature with Cushing's syndrome (Taylor et al., 1949; Sydnor et al.,-1953 ; Paris et a., 1954) significant depletion in the Sayer's test was only found in 2; of these, 1 had an adrenal tumour and 1 had adrenal hyperplasia. No pituitary lesion was described in any of their patients.
The occurrence of ACTH in blood following adrenalectomy has been studied in animals. ACTH is not detectable in unstressed normal male rats. Following adrenalectomy and maintenance on glucose-saline solution, ACTH was not detectable in pooled serum collected from rats one week, or four, or eight months after operation, but after three weeks The Neural Intermediate Lobe Hormone ("B") By F. W. LANDGREBE, D.Sc., and G. M. MITCHELL, M.B.
Welsh National School of Medicine, Cardiff EXTRACTS of the pituitary gland exhibit many pharmacological activities. Of the various activities found in extracts of the gland, the melanophore expanding was one of the first to be recognized as a hormone in amphibia over thirty years ago by Hogben. It caused a darkening of the skin so that the animal appeared black on a white background and he called it "B-hormone" (Hogben and Slome, 1931) . After a dorsal lymph-sac injection of the extracts into frogs and toads, he measured the expansion of the melanophores of the skin according to an arbitrary scale (Hogben and Gordon, 1930) . S Landgrebe, Stehle, Waring and others spent many years developing methods of manufacture of "B" from the posterior lobes of domestic animals such as the pig and ox and we have finally obtained from pig posterior lobe pituitary an extract with a potency of about 1,000 i.u./mg. (Landgrebe and Mitchell, 1954) . This was subjected to electrophoresis and the product, a pure polypeptide, contained about 1,500 i.u./mg. Harris and Roos (1956) determined the amino-acid sequence of this material. "B"-containing extracts can be obtained from the pituitary glands of many other than domestic animals. It is present in large amounts in extracts of the hypophysis of man, ox, guinea-pig, horse, sheep, reptiles (turtles and alligators) and toads. Houssay has found it in the skate pituitary in which the neural lobe is very rudimentary. Table II shows the .. .10 , amount of "B" activity in extracts of the posterior lobe of the pituitaries of certain species. The values for "B" in extracts of ox and pig glands probably represent the maximum amount present since these glands were obtained almost immediately after death. The activity stated for the other glands is probably low since they were obtained some time after killing the animal and "B" activity quickly disappears. Since "B" is so widespread and occurs in such amounts in the animal kingdom, it probably has some function in mammals.
In the ox and pig the gland is easily divisible at the hypophyseal cleft but the intermediate lobe is inseparable from the posterior lobe. The cells of the intermediate lobe are said to be responsible for "B" production. In man, however, this is not so. In foetal life there is a layer of cells which resemble the intermediate lobe but it disappears in early life and we are left with areas of "basophil-cell invasion". In the rat similar basophil cells in the anterior lobe are believed to produce ACTH. Since "B" and ACTH are similar chemically, the areas of "basophil-cell invasion" may be responsible for "B" production in the human. However, our own evidence is that the anterior lobe of the human gland contains on a weight basis as much as the areas of "basophil-cell invasion" (Morris et al., 1956) .
The fact that the human gland contains such a large amount of "B" leads us to wonder if it has some significant function about which we know nothing, or if it is a "brick" used in the building of a more complex polypeptide. If we compare the structures of ACTH and "B" we see a heptapeptide present in both. If the lysine and serine in "B" were changed 15... then there would be eleven amino acids which would be similar, and it may be that the simpler "B" molecule or part of it is used for the building of the more complex 39 amino-acid ACTH.
The various ACTH preparations used in clinical medicine are made from either ox or pig glands and each sample contains large amounts of "B" which could be partly intrinsic to the ACTH molecule but largely due to contamination.
As well as estimating the "B" activity in extracts of pituitary glands we have also attempted without success to measure the amount of "B" in blood and urine. Our test, using xenopus, is probably not sensitive enough since there is probably less than 0-01 i.u. per 100 ml. of blood. There have been many claims that there is an increase in "B" in blood in many diseases but you cannot be certain that the substance being measured is "B". Before you can state that it is "B" three criteria must be fulfilled:
(1) The substance must produce expansion of melanophores in the intact animal.
(2) The substance must produce expansion of melanophores in the hypophysectomized animal.
(3) The substance must emanate from the pituitary. We know that many amines such as adrenaline, phenylalkylamines, &c., cause darkening in amphibia and it is possible that similar substances may be extracted and cause the darkening effect.
In pregnancy, too, the estimation of a darkening substance in the urine is used in the Konsuloff (1934) test when the test animal is Rana esculenta. If you use xenopus as the test animal you find darkening in a small percentage of cases only. In one sample of 105 known pregnancies only 10 gave a positive effect on melanophores of xenopus (Hobson, 1958) . This substance was claimed to be "B" but it does not satisfy the three criteria stated above and it is unlikely that it is "B".
We have injected subcutaneously large doses of "B" into rabbits but failed to extract any "B" from the urine. Even if injected i.v. the "B" content of blood is only high for a short period of time. So it does seem that the darkening effect reported by many workers is not specifically due to "B" and until we isolate either one or more of these substances from urine we cannot be sure of either their chemical nature or their source.
